|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/20 | (2006.01) |
| A61K 31/7072 | (2006.01) | ||
| A61P 31/00 | (2006.01) |
| (11) | Patento numeris | 2826784 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14179358.8 |
| Europos patento paraiškos padavimo data | 2008-03-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 909315 P | 2007-03-30 | US | |
| 982309 P | 2007-10-24 | US | |
| 53015 | 2008-03-21 | US |
| (72) |
Du, Jinfa, US
Wang, Peiyuan, US
Nagarathnam, Dhanapalan, US
Sofia, Michael Joseph, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside |
| Composition comprising a HCV NS3 protease inhibitor and a phosphoramidate prodrug of 2'-deoxy-2'-fluoro-2'-C-methyluridine nucleoside |